Correlation Between Zenicor Medical and Devyser Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zenicor Medical and Devyser Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zenicor Medical and Devyser Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zenicor Medical Systems and Devyser Diagnostics AB, you can compare the effects of market volatilities on Zenicor Medical and Devyser Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zenicor Medical with a short position of Devyser Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zenicor Medical and Devyser Diagnostics.

Diversification Opportunities for Zenicor Medical and Devyser Diagnostics

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Zenicor and Devyser is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Zenicor Medical Systems and Devyser Diagnostics AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Devyser Diagnostics and Zenicor Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zenicor Medical Systems are associated (or correlated) with Devyser Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Devyser Diagnostics has no effect on the direction of Zenicor Medical i.e., Zenicor Medical and Devyser Diagnostics go up and down completely randomly.

Pair Corralation between Zenicor Medical and Devyser Diagnostics

Assuming the 90 days trading horizon Zenicor Medical Systems is expected to under-perform the Devyser Diagnostics. In addition to that, Zenicor Medical is 1.75 times more volatile than Devyser Diagnostics AB. It trades about -0.1 of its total potential returns per unit of risk. Devyser Diagnostics AB is currently generating about -0.17 per unit of volatility. If you would invest  13,450  in Devyser Diagnostics AB on September 5, 2024 and sell it today you would lose (1,000.00) from holding Devyser Diagnostics AB or give up 7.43% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Zenicor Medical Systems  vs.  Devyser Diagnostics AB

 Performance 
       Timeline  
Zenicor Medical Systems 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zenicor Medical Systems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Zenicor Medical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Devyser Diagnostics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Devyser Diagnostics AB are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Devyser Diagnostics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Zenicor Medical and Devyser Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zenicor Medical and Devyser Diagnostics

The main advantage of trading using opposite Zenicor Medical and Devyser Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zenicor Medical position performs unexpectedly, Devyser Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Devyser Diagnostics will offset losses from the drop in Devyser Diagnostics' long position.
The idea behind Zenicor Medical Systems and Devyser Diagnostics AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Transaction History
View history of all your transactions and understand their impact on performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account